市场见解

Are AnteoTech (ASX:ADO) rapid COVID tests available in Australia?

The company’s rapid testing device still isn’t able to be used in Australia.
The post Are AnteoTech (ASX:ADO) rapid COVID tests available in Australia? appeared first on The Motley Fool Australia. –

The AnteoTech Ltd (ASX: ADO) share price has soared since the start of the pandemic as the company has worked to create a COVID-19 rapid antigen test.

Enthusiasm surrounding the now-developed point-of-care rapid testing device has helped boost the company’s stock by more than 1000% since the start of 2020.

AnteoTech’s EuGeni testing device is now reportedly widely used in the United States and Europe. However, the Queensland-based company’s test is facing ongoing delays for Australian approvals, much to the frustration of AnteoTech’s boss.

At the time of writing, the AnteoTech share price is 31.5 cents, 3.28% higher than its previous close.

For context, the S&P/ASX 200 Index (ASX:XJO) is up 0.86% right now.

Is the AnteoTech COVID rapid test locked in TGA delays?

AnteoTech’s calls for more rapid testing have been answered, but the company’s product still can’t be found in Australia.

AnteoTech CEO Derek Thomson reportedly told Queensland’s The Courier Mail, the company pushed the state government to accept rapid tests as a measure to screen for the virus. Last week, the publication quoted Thomson as saying:

We’ve always said that rapid testing has a place to be used to control the pandemic and now we’re seeing that play out…

There’s too much stress on the PCR testing system in all Australian states and it’s really not necessary to go to the full extent of doing a PCR test when you’ve got rapid tests readily available now.

Days after Thomson’s comments, Queensland Premier Annastacia Palaszczuk declared the state would allow arriving travellers’ entry after they receive a negative rapid test. Previously, arrivals had to receive a negative PCR test.

Further, Palaszczuk announced close contacts in Queensland will soon be given access to 18 million free rapid antigen tests at COVID-19 testing sites yesterday, saying:

We know the transition to RAT tests for close contacts will reduce some of the pressure we have seen at testing clinics in recent weeks, ensuring those with symptoms can be tested sooner.

Still, Thomson reportedly noted it’s “quite frustrating” the Therapeutic Goods Administration hasn’t approved the use of the AnteoTech’s COVID-19 rapid antigen test.

That’s despite the potential its approval could lead to millions more 15-minute tests being made available to Australians. The EuGeni testing device has been proven to be accurate 97.3% of the time.

The post Are AnteoTech (ASX:ADO) rapid COVID tests available in Australia? appeared first on The Motley Fool Australia.

Should you invest $1,000 in AnteoTech right now?

Before you consider AnteoTech, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and AnteoTech wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Why Anteotech, Bega Cheese, Humm, and Syrah shares are racing higher

Here’s why the Anteotech (ASX:ADO) share price is spiking 13% today

AnteoTech (ASX:ADO) share price falls on TGA update

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!